Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
5.59
-0.14 (-2.44%)
At close: Sep 10, 2025, 4:00 PM
5.48
-0.11 (-1.97%)
After-hours: Sep 10, 2025, 5:50 PM EDT
Neogen Market Cap
Neogen has a market cap or net worth of $1.21 billion as of September 10, 2025. Its market cap has decreased by -65.09% in one year.
Market Cap
1.21B
Enterprise Value
2.00B
1-Year Change
-65.09%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since December 1, 1998, Neogen's market cap has increased from $43.50M to $1.21B, an increase of 2,691.21%. That is a compound annual growth rate of 13.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 1.24B | -52.69% |
Dec 31, 2024 | 2.63B | -39.52% |
Dec 29, 2023 | 4.35B | 164.86% |
Dec 30, 2022 | 1.64B | -66.44% |
Dec 31, 2021 | 4.89B | 15.90% |
Dec 31, 2020 | 4.22B | 22.74% |
Dec 31, 2019 | 3.44B | 15.87% |
Dec 31, 2018 | 2.97B | -5.55% |
Dec 29, 2017 | 3.14B | 25.42% |
Dec 30, 2016 | 2.51B | 18.64% |
Dec 31, 2015 | 2.11B | 15.26% |
Dec 31, 2014 | 1.83B | 10.30% |
Dec 31, 2013 | 1.66B | 53.65% |
Dec 31, 2012 | 1.08B | 50.01% |
Dec 30, 2011 | 720.90M | -22.72% |
Dec 31, 2010 | 932.80M | 77.47% |
Dec 31, 2009 | 525.60M | 44.32% |
Dec 31, 2008 | 364.20M | -3.50% |
Dec 31, 2007 | 377.40M | 84.73% |
Dec 29, 2006 | 204.30M | 18.37% |
Dec 30, 2005 | 172.60M | -5.84% |
Dec 31, 2004 | 183.30M | 17.80% |
Dec 31, 2003 | 155.60M | 70.05% |
Dec 31, 2002 | 91.50M | -14.49% |
Dec 31, 2001 | 107.00M | 131.60% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 663.10B |
Johnson & Johnson | 429.00B |
AbbVie | 370.61B |
UnitedHealth Group | 290.04B |
AstraZeneca | 251.37B |
Novartis AG | 249.66B |
Novo Nordisk | 242.52B |
Abbott Laboratories | 230.09B |